Reviving liver health with ayurveda: a systematic review of non-alcoholic fatty liver disease management

Harshitha K. S.; Mythrey R. C.

doi:10.18203/2320-6012.ijrms20251649

Authors

Harshitha K. S. Department of PG and PhD studies in Kayachikitsa, Sri Kalabhyraweshwara Ayurvedic Medical College, Hospital and Research Centre, Bengaluru, Karnataka, India
Mythrey R. C. Department of PG and PhD Studies in Kayachikitsa, Government Ayurveda Medical College and Hospital, Mysuru, Karnataka, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20251649

Keywords:

Liver cirrhosis, Ayurveda, Liver health, Traditional Indian medicine, Management, NAFLD, Yakritodara

Abstract

Liver diseases (Yakrit Roga) constitute a global health concern. Non-alcoholic fatty liver disease (NAFLD), which exhibits a global prevalence of 25%, is on the rise, raising significant concerns regarding its impact on global health. NAFLD results in the accumulation of triglycerides and unbound fatty acids within the hepatic tissue. This systematic literature review presents a comprehensive examination of the restoration of liver health in individuals with NAFLD through the principles of Ayurveda. It analysed the results in this discipline from its inception in 2016 to the latest research published in recent years. utilizing PubMed and Scopus, employing specific inclusion and exclusion criteria. Based on the research results, it can be concluded that there is existing evidence regarding both the safety and effectiveness of Ayurvedic interventions along in the treatment of NAFLD. The combined effects of Triphala Guggulu and Arogyavardhini Vaṭi in combination with Pathya (Ayurvedic diet and exercise) showed promising combination. Physical exercise and dietary management are the principal methods for regulating the progression of NAFLD and significantly elevates the probability of non-alcoholic steatohepatitis, (NASH) cirrhosis, and hepatocellular carcinoma.

Metrics

Metrics Loading ...

References

Pan S, Ghosh M, Mukherjee U, Ghosh S, Banerjee S, Sarkar R. The importance of Ayurveda, the traditional Indian system of medicine for the treatment of liver diseases. 2024.

Sharma B, Sharma M, Rai S, More AB. Review of clinical and preclinical studies on Ayurveda drugs used in management of liver diseases: A search for proof of concept. J Indian System Med. 2021;9(4):226-34.

Mawar B, Yadava RK, Mahto RR. Management Of Yakriddalyudar (Liver Disorders) Wsr To Non-Alcoholic Steatohepatitis (NASH). Pharma Science Monitor. 2020;11(3):1-15.

Ganesh S, Joshi N, Jain MK, Sharma L, Desai A, Rafiq M, et al. Clinical and safety evaluation of Liv. 52 in alcoholic liver disease: a review. Gastroenterol Insights. 2022;13(4):377-86. DOI: https://doi.org/10.3390/gastroent13040037

Nasir F, Itrat M, Khan F. Evidence-Based Unani Pharmacotherapeutics for the Treatment of Non-Alcoholic Fatty Liver Disease: A Mechanistic Review. Alternative Therapies Health Med. 2024;30(8):32-42.

Sharma B, Sharma M, Rai S, More AB. Review of clinical and preclinical studies on Ayurveda drugs used in management of liver diseases: A search for proof of concept. J Indian System Med. 2021;9(4):226-34. DOI: https://doi.org/10.4103/jism.jism_60_21

Shivnitwar SK, Gilada I, Rajkondawar AV, Ojha SK, Katiyar S, Arya N, et al. Safety and Effectiveness of Liv. 52 DS in Patients with Varied Hepatic Disorders: An Open-Label, Multi-centre, Phase IV Study. Cureus. 2024;16(5):e60898. DOI: https://doi.org/10.7759/cureus.60898

Kantharia C, Kumar M, Jain MK, Sharma L, Jain L, Desai A. Hepatoprotective effects of Liv. 52 in chronic liver disease preclinical, clinical, and safety evidence: a review. Gastroenterol Insights. 2023;14(3):293-308. DOI: https://doi.org/10.3390/gastroent14030021

Panda AK, Bhuyan GC, Rao MM. Ayurvedic intervention for hepatobiliary disorders: Current scenario and future prospect. J Tradit Med Clin Natur. 2017;6(210):2.

Bhatt N, Deshpande M, Namewar P, Pawar S. A review of classical, proprietary and patented Ayurved products and their ingredients in liver/spleen diseases. Int J Pharmaceut Sci Res. 2018;9(10):4056-70.

Zhu X, Bian H, Gao X. The potential mechanisms of berberine in the treatment of nonalcoholic fatty liver disease. Molecules. 2016;21(10):1336. DOI: https://doi.org/10.3390/molecules21101336

Jiang Y, Zhao L, Ma J, Yang Y, Zhang B, Xu J, et al. Preventive mechanisms of Chinese Tibetan medicine Triphala against nonalcoholic fatty liver disease. Phytomedicine. 2024;123:155229. DOI: https://doi.org/10.1016/j.phymed.2023.155229

Varsakiya J, Kathad D, Kumari R, Nayak S. Ayurvedic Management of Yakrit Vidradhi (Liver Abscess)–A Case Report. Int Res J Ayurveda Yoga 2023;6(4):38-48. DOI: https://doi.org/10.47223/IRJAY.2023.6406

Ranjan S, Pattanayak SP, Ranjan G. Polyherbal Approach for the Management of Alcohol-Induced Liver Disease, their Complications and Hangover: A Review. Int J Gastroenterol Hepatol Dis. 2024;04. DOI: https://doi.org/10.2174/0126662906338140241115102403

Raut A, Dhami-Shah H, Phadke A, Shindikar A, Udipi S, Joshi J, et al. Picrorhiza kurroa, Royle ex Benth: Traditional uses, phytopharmacology, and translational potential in therapy of fatty liver disease. J Ayurveda Integrative Med. 2023;14(1):100558. DOI: https://doi.org/10.1016/j.jaim.2022.100558

Das J, Sarkar BR. A Review of Ethnomedicinal Plants And Their Traditional Uses For The Treatment Of Hepatobiliary Disease By Different Tribes Of North-East India. IJP. 2023;10(6):284-98.

Nendouvhada LP, Sibuyi NR, Fadaka AO, Meyer S, Madiehe AM, Meyer M, et al. Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. Int J Molecular Sci. 2024;25(11):5571. DOI: https://doi.org/10.3390/ijms25115571

Jangid SK, Binorkar SV, Chhatbar DK, Ravi AK. Management of biliary calculi through Ayurveda-A case report. AYU. 2024;45(2):72-8. DOI: https://doi.org/10.4103/ayu.ayu_105_24

Narendra B, Manasi D. A Comparative Review on Medicinal Plants Used for the Liver Disorders as in Ayurved, Siddha and Unani [ASU] Systems of Medicine Part 2-Phytochemical and Pharmacological Aspects. 2021;11(6):44034-68.

Bhagiya SG, Shukla RB, Joshi NP, Thakar AB. A single-case study of management of Jalodara (ascites) Ayu. 2017;38:144-7. DOI: https://doi.org/10.4103/ayu.AYU_176_17

Bhatt N, Deshpande M. A critical review of Indian medicinal plants for hepatocellular carcinoma. Int J Ayurvedic Herb Med. 2022;12:4150-86.

Yadav B, Kuchewar V, Bharti. A protocol for an open-label randomized parallel group clinical study on nonalcoholic fatty liver disease (NAFLD). J Med Pharmaceut Allied Sci. 2024;13-I(4):6681-6. DOI: https://doi.org/10.55522/jmpas.v13i4.6470

Banerjee T, Sarkar A, Ali SZ, Bhowmik R, Karmakar S, Halder AK, et al. Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms. Planta Medica. 2024;90(9):675-707. DOI: https://doi.org/10.1055/a-2277-4805

Girhepunje KS, Gupta V, Jain R, Nakanekar A, Singh OP. Effect of integrated paracentesis and oral Vardhaman Pippali Rasayan (vpr) therapy in ascites due to alcoholic liver cirrhosis: A case report World J Pharm Sci. 2017;6:1402-17.

Ratha KK, Meher SK. Ayurvedic management of acute viral hepatitis: A case report. Indian J Case Rep. 2018;4:511-4. DOI: https://doi.org/10.32677/IJCR.2018.v04.i06.035

Singh MP, Kuchewar V. Management of Jalodara (ascites) through treatment principles of Ayurveda: A case report. J Indian Sys Med. 2019;7:185-8. DOI: https://doi.org/10.4103/JISM.JISM_53_19

Aswathy G, Dharmarajan P, Sharma AR, Sasikumar VK, Vasudevan Nampoothiri MR. Ayurvedic management of cirrhotic ascites Anc Sci Life. 2016;35:236-9. DOI: https://doi.org/10.4103/0257-7941.188183

Ghezelbash B, Shahrokhi N, Khaksari M, Asadikaram G, Shahrokhi M, Shirazpour S. Protective roles of Shilajit in modulating resistin, adiponectin, and cytokines in rats with non-alcoholic fatty liver disease. Chinese J Integrative Med. 2022;28(6):531-7. DOI: https://doi.org/10.1007/s11655-022-3307-3

Zarzour RH, Ahmad M, Asmawi MZ, Kaur G, Saeed MAA, Al-Mansoub MA, et al. Phyllanthus niruri standardized extract alleviates the progression of non-alcoholic fatty liver disease and decreases atherosclerotic risk in Sprague–Dawley rats. Nutrients. 2027;9(7):766. DOI: https://doi.org/10.3390/nu9070766

Zhang B, Luo X, Han C, Liu J, Zhang L, Qi J, et al. Terminalia bellirica ethanol extract ameliorates nonalcoholic fatty liver disease in mice by amending the intestinal microbiota and faecal metabolites. J Ethnopharmacol. 2023;305:116082. DOI: https://doi.org/10.1016/j.jep.2022.116082

Baselga-Escudero L, Souza-Mello V, Pascual-Serrano A, Rachid T, Voci A, Demori I, et al. Beneficial effects of the Mediterranean spices and aromas on non-alcoholic fatty liver disease. Trends Food Sci Technol. 2017;61:141-59. DOI: https://doi.org/10.1016/j.tifs.2016.11.019